Congress Wealth Management LLC DE Acquires 3,964 Shares of Integer Holdings Co. (NYSE:ITGR)

Congress Wealth Management LLC DE lifted its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 5.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 79,094 shares of the medical equipment provider’s stock after buying an additional 3,964 shares during the period. Congress Wealth Management LLC DE’s holdings in Integer were worth $10,482,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Mather Group LLC. lifted its stake in Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 143 shares during the period. Lee Danner & Bass Inc. bought a new position in Integer during the fourth quarter valued at approximately $27,000. R Squared Ltd purchased a new stake in Integer in the fourth quarter worth approximately $44,000. Versant Capital Management Inc boosted its holdings in Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 183 shares during the last quarter. Finally, Principal Securities Inc. raised its stake in Integer by 31.2% during the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider’s stock valued at $85,000 after buying an additional 152 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on ITGR shares. Oppenheimer downgraded Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Truist Financial raised their target price on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Benchmark upped their price target on shares of Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Friday, February 21st. Wells Fargo & Company reissued an “overweight” rating and issued a $160.00 price objective on shares of Integer in a report on Tuesday, December 3rd. Finally, KeyCorp boosted their target price on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $149.00.

Integer Price Performance

NYSE ITGR opened at $117.13 on Tuesday. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62. Integer Holdings Co. has a 12 month low of $107.11 and a 12 month high of $146.36. The stock has a market cap of $3.94 billion, a price-to-earnings ratio of 34.86, a PEG ratio of 1.72 and a beta of 1.24. The company’s 50 day moving average is $132.23 and its two-hundred day moving average is $132.29.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). The firm had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. As a group, research analysts anticipate that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.